Gyrodyne LLC Dossier
Qualitative Analysis
Business overview
Gyrodyne, LLC (NASDAQ: GYRO) is a real estate investment company organized as a New York limited liability company. The company owns and manages a diversified portfolio of commercial real estate properties, primarily medical office and industrial properties, located in Suffolk and Westchester Counties, New York. Its core holdings include a 63-acre site in St. James, New York (the Flowerfield complex), and a medical office park on 13.8 acres in Cortlandt Manor, New York. Gyrodyne is currently operating under a board-approved plan of liquidation and dissolution, focusing on securing value-enhancing zoning entitlements for its properties to maximize their development flexibility and market value prior to sale.
Research as of 20 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Focusing on securing land-use regulatory approvals and entitlements for the remaining real estate holdings (Flowerfield and Cortlandt Manor properties) to maximize their market value prior to sale, followed by the orderly wind-down and dissolution of the company.
Expected impact: Maximizes the final liquidating distributions to shareholders, currently estimated at $11.79 per share.
Executing the purchase and sale agreement with B2K Smithtown LLC for approximately 49 acres of vacant land within the Flowerfield complex for a price range of $24,000,000 to $28,740,000.
Expected impact: Generates gross proceeds of up to $28.74 million to support the liquidation plan.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
Serves as the primary transaction to monetize a major portion of the Flowerfield property, aligning with the company's liquidation strategy to maximize shareholder value.
Terms: Purchase price range of $24,000,000 to $28,740,000, subject to subdivision, site plan approvals, and a $4.02 million sewer and infrastructure credit.